Needham & Company marked Alcon (NYSE:ALC) as its top pick for 2025, adding the medtech stock to its Conviction List while ...

Neumora Therapeutics (NASDAQ:NMRA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & ...

Needham & Company LLC reissued their buy rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a research report sent to investors on Friday,Benzinga reports. Needham & Company ...

Laura Martin, Needham and Company senior internet and media analyst, joins 'Power Lunch' to discuss the big winners in Big ...

Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced that Ashley Johnson, ...

Investing.com -- Roku (ROKU) shares gained momentum in premarket trading on Wednesday following an optimistic note from Needham&Company, which reiterated its Buy rating and $100 price target.

In a report released today, Joseph Stringer from Needham maintained a Hold rating on Lexicon Pharmaceuticals (LXRX – Research Report). The ...

Needham analyst Michael Matson maintained a Hold rating on Teleflex (TFX – Research Report) today. The company’s shares closed last Friday at ...

Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today announced ...

Investing.com -- Needham&Company marked Alcon (NYSE:ALC) as its top pick for 2025, adding the medtech stock to its Conviction List while raising the price target to $108 from $103. The company's ...